Skip to main content
The Markets by Proactive
Go to Proactive UK
Proactive UK has moved. Proactive’s coverage of London’s small caps continues on proactiveinvestors.com Go there →
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Coverage of London’s small caps continues on proactiveinvestors.com
Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK

Software & services

EnWave bolsters intellectual property portfolio with nine patent approvals around the world

The company currently holds fifteen families of patents related to its Radiant Energy Vacuum dehydration technology

EnWave Corporation (CVE:ENW) (OTCMKTS:NWVCF) announced on Friday that it has received nine patent approvals from a variety of international patent offices.

The company currently holds fifteen families of patents related to its Radiant Energy Vacuum (REV) dehydration technology that have been approved in multiple international jurisdictions.

In the last three months, EnWave has earned approval from the Chilean, Indonesian and Mexican patent offices for its Modular nutraREV patent; from the Australian and Canadian offices for its Frozen-In process; from the US for the quantaREV apparatus patent; from Australia for its vacuum-microwaved puffed-snack patent; and, most importantly, from Canada for the dehydration and decontamination of cannabis using REV technology.

READ: EnWave to license its unique REV dehydration technology to the US cannabis market

In addition, EnWave completed and submitted six additional patent applications to the International Patent Cooperation Treaty (PCT) examiner for review. The company also has a large amount of additional pending national phase applications that should be approved in the coming months.

Vancouver-based EnWave prides itself on offering the most scalable and reliable proprietary vacuum-microwave technology with the most comprehensive set of innovations and solutions available, which accelerates product and process development and unlocks value for its global partners.

The company is developing commercial applications for its REV dehydration technology in the cannabis, food and pharmaceutical industries.

Contact Andrew Kessel at andrew.kessel@proactiveinvestors.com

Follow him on Twitter @andrew_kessel

Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK